Microsoft
About Microsoft
133 articles about Microsoft
-
OSE Immunotherapeutics Announces Collaboration with Microsoft
6/16/2022
OSE Immunotherapeutics SA announces that the Company is one of the first biotech startup companies selected by Microsoft France to be a privileged partner of its support program for French Biotech & Deeptech Startups.
-
UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development
2/23/2021
Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases in immunology and neurology
-
Broad Institute and Verily partner with Microsoft to accelerate the next generation of the Terra platform for health and life science research
1/11/2021
Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human diseases
-
Ansys collaborates with Microsoft to enhance cloud engineering productivity for customers
10/29/2020
Ansys is teaming with Microsoft to deploy public cloud high-performance computing (HPC) and digital twin solutions that will significantly advance the state of the art in engineering simulation across several key industries
-
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation
5/26/2020
"The Fight Is In Us" Campaign Seeks to Mobilize COVID-19 Survivors to Accelerate the Development of Potentially Lifesaving Therapies [26-May-2020] REDMOND, Wash. and NEW YORK , May 26, 2020 /PRNewswire/ -- A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies, philanthropic organizations
-
Clinical Catch-Up: May 4-8
5/11/2020
It’s the first time in several weeks that the number of non-COVID-19-related clinical trial stories outnumber the COVID-19-related stories. It’s also a hopeful sign that some of the rest of the clinical trials are getting back on track. Here’s a look. -
Nuance and Microsoft partner to transform the doctor-patient experience
10/17/2019
Strategic partnership accelerates the delivery of ambient technologies to reduce clinician burnout by enabling doctors to focus on patients, while AI focuses on administrative tasks
-
With Microsoft Deal, Novartis Continues to Focus its Future Development on AI, Machine Learning
10/2/2019
Swiss pharma giant Novartis has partnered with tech giant Microsoft and launched its Novartis AI innovation lab as a means to leverage data and artificial intelligence to transform drug discovery and development. -
Gibson Assembly® Advances Field of DNA Digital Data Storage
10/1/2019
Gibson Assembly strategy successfully employed to significantly increase the throughput of DNA data storage and retrieval
-
GSK's Emma Walmsley to Bring Biopharma and Healthcare Expertise to Microsoft Board of Directors
9/23/2019
Microsoft announced that Emma Walmsley, chief executive officer of GlaxoSmithKline, had been nominated to the company’s board of directors. -
Microsoft And Providence St. Joseph Health Announce Strategic Alliance To Accelerate The Future Of Care Delivery
7/8/2019
Providence St. Joseph Health, in partnership with Microsoft, will develop and deploy new health care technologies that will harness the power of Microsoft Azure and AI with clinical expertise to transform the care experience
-
AstraZeneca announced a long-term collaboration deal with BenevolentAI, a UK-based company focused on combining computational medicine and advanced artificial intelligence.This deal only marks one of the most recent AI team-ups announced in the biopharma industry.
-
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
-
The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.
-
Binovi™ by Eyecarrot Partners With Microsoft's Machine Learning and Artificial Intelligence Platform Azure Databricks
2/28/2019
Eyecarrot Innovations Corp is pleased to announce it has initiated implementation of Microsoft's Machine Learning and Artificial Intelligence platform Azure Databricks.
-
Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey
2/20/2019
Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey
-
Microsoft awards grant to Tribal Digital Village and Numbers4Health to expand internet access and solutions for rural and underserved communities in California
8/1/2018
The grant will provide broadband access and telehealth solutions in Valley Center and Compton, California
-
Microsoft awards grant to Numbers4Health to expand its telehealth solution to rural Texas
8/1/2018
The grant will help expand Numbers4Health's telehealth solution across the U.S. including rural Texas
-
Microsoft awards grant to Numbers4Health to expand its telehealth solution to rural Maine
8/1/2018
The grant will help expand Numbers4Health's telehealth solution across the U.S. including rural Maine
-
Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease
1/4/2018
Adaptive Biotechnologies announced today their partnership with Microsoft to map the genetics of the human immune system, or immunome, in order to detect cancers and other diseases in their earliest stage, when they can be more effectively treated.